Honz Pharmaceutical Co., Ltd. (SHE:300086)
5.55
-0.03 (-0.54%)
Jul 4, 2025, 2:45 PM CST
Honz Pharmaceutical Revenue
Honz Pharmaceutical had revenue of 112.42M CNY in the quarter ending March 31, 2025, with 7.33% growth. This brings the company's revenue in the last twelve months to 480.49M, down -28.25% year-over-year. In the year 2024, Honz Pharmaceutical had annual revenue of 472.82M, down -36.07%.
Revenue (ttm)
480.49M
Revenue Growth
-28.25%
P/S Ratio
5.26
Revenue / Employee
729.12K
Employees
659
Market Cap
2.53B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 472.82M | -266.75M | -36.07% |
Dec 31, 2023 | 739.57M | 203.82M | 38.05% |
Jan 1, 2023 | 535.75M | -300.82M | -35.96% |
Jan 1, 2022 | 836.57M | -85.08M | -9.23% |
Dec 31, 2020 | 921.64M | -86.79M | -8.61% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |